Rosuvastatin changes cytokine expressions in ischemic territory and preserves heart function after acute myocardial infarction in rats

Journal of Cardiovascular Pharmacology and Therapeutics

Volumn 18, Issue 2, 2013, Pages 162-176

  Hu, Xinying ^a   Sun, Aijun ^a   Xie, Xinxing ^a   Huang, Zheyong ^a   Jia, Jianguo ^a   Yao, Ruiming ^a   Ge, Junbo ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

acute myocardial infarction; cytokines; progenitor cells; rosuvastatin

Indexed keywords

CD133 ANTIGEN; CHEMOKINE RECEPTOR CXCR4; INTERCELLULAR ADHESION MOLECULE 1; PLACEBO; ROSUVASTATIN; STEM CELL FACTOR; STROMAL CELL DERIVED FACTOR 1; THY 1 ANTIGEN; VASCULOTROPIN;

ACUTE HEART INFARCTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL AGGREGATION; CONTROLLED STUDY; CORONARY ARTERY LIGATION; DOWN REGULATION; DRUG EFFECT; ECHOCARDIOGRAPH; HEART FUNCTION; HEART INFARCTION PREVENTION; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HEART VENTRICLE REMODELING; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RECEPTOR DOWN REGULATION; STEM CELL; SYSTOLE; THORACOTOMY; UPREGULATION; WESTERN BLOTTING;

ANIMALS; CYTOKINES; FLUOROBENZENES; GENE EXPRESSION REGULATION; HEART; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; PYRIMIDINES; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; SULFONAMIDES; VENTRICULAR REMODELING;

EID: 84873639362     PISSN: 10742484     EISSN: 19404034     Source Type: Journal    
DOI: 10.1177/1074248412465015     Document Type: Article

References (34)

1. Wei HM, Wong P, Hsu LF, Shim W. Human bone marrow-derived adult stem cells for post-myocardial infarction cardiac repair: current status and future directions. Singapore Med J. 2009 ; 50 (10). 935-942
2. Wojakowski W, Tendera M. Mobilization of bone marrow-derived progenitor cells in acute coronary syndromes. Folia Histochem Cytobiol. 2005 ; 43 (4). 229-232
3. Abbott JD, Huang Y, Liu DG, Hickey R, Krause DS, Giordano FJ. Stromal cell-derived factor-1 plays a critical role in stem cell recruitment to the heart after myocardial infarction but is not sufficient to induce homing in the absence of injury. Circulation. 2004 ; 110 (21). 3300-3305
4. Kucia M, Dawn B, Hunt G, et al. Cells expressing early cardiac markers reside in the bone marrow and are mobilized into the peripheral blood after myocardial infarction. Circ Res. 2004 ; 95 (12). 1191-1199
5. Kostapanos MS, Milionis HJ, Elisaf MS. An overview of the extra-lipid effects of rosuvastatin. J Cardiovasc Pharmacol Ther. 2008 ; 13 (3). 157-174
6. Sparrow CP, Burton CA, Hernandez M, et al. Simvastatin has anti-inflammatory and antiatherosclerotic activities independent of plasma cholesterol lowering. Arterioscler Thromb Vasc Biol. 2001 ; 21 (1). 115-121
7. Dimmeler S, Aicher A, Vasa M, et al. HMG-CoA reductase inhibitors(statins) increase endothelial progenitor cells via the PI3-kinase/Akt pathway. J Clin Invest. 2001 ; 108 (3). 391-397
8. Crisby M, Nordin-Fredriksson G, Shah PK, Yano J, Zhu J, Nilsson J. Pravastatin treatment increases collagen content and decreases lipid content, inflammation, metalloproteinases, and cell death in human carotid plaques: implications for plaque stabilization. Circulation. 2001 ; 103 (7). 926-933
9. Kang BY, Mehta JL. Rosuvastatin attenuates Ang II-mediated cardiomyocyte hypertrophy via inhibition of LOX-1. J Cardiovasc Pharmacol Ther. 2009 ; 14 (4). 283-291
10. Wexler SA, Donaldson C, Denning-Kendall P, Rice C, Bradley B, Hows JM. Adult bone marrow is a rich source of human mesenchymal 'stem' cells but umbilical cord and mobilized adult blood are not. Br J Haematol. 2003 ; 121 (2). 368-374
11. Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science. 1999 ; 284 (5411). 143-147
12. Smith RR, Barile L, Messina E, Marbán E. Stem cells in the heart: what's the buzz all about? - Part 1: preclinical considerations. Heart Rhythm. 2008 ; 5 (5). 749-757
13. Rood PM, Calafat J, von dem Borne AE, Gerritsen WR, van der Schoot CE. Immortalisation of human bone marrow endothelial cells: characterisation of new cell lines. Eur J Clin Invest. 2000 ; 30 (7). 618-629
14. Quirici N, Soligo D, Caneva L, Servida F, Bossolasco P, Deliliers GL. Differentiation and expansion of endothelial cells from human bone marrow CD133(+) cells. Br J Haematol. 2001 ; 115 (1). 186-194
15. Kucia M, Jankowski K, Reca R, et al. CXCR4-SDF-1 signalling, locomotion, chemotaxis and adhesion. J Mol Histol. 2004 ; 35 (3). 233-245
16. Cheng Z, Ou L, Zhou X, et al. Targeted migration of mesenchymal stem cells modified with CXCR4 gene to infarcted myocardium improves cardiac performance. Mol Ther. 2008 ; 16 (3). 571-579
17. Pasha Z, Wang Y, Sheikh R, Zhang D, Zhao T, Ashraf M. Preconditioning enhances cell survival and differentiation of stem cells during transplantation in infarcted myocardium. Cardiovasc Res. 2008 ; 77 (1). 134-142
18. Zheng H, Dai T, Zhou B, et al. SDF-1alpha/CXCR4 decreases endothelial progenitor cells apoptosis under serum deprivation by PI3K/Akt/eNOS pathway. Atherosclerosis. 2008 ; 201 (1). 36-42
19. Chen M, Xie HQ, Deng L, et al. Stromal cell-derived factor-1 promotes bone marrow-derived cells differentiation to cardiomyocyte phenotypes in vitro. Cell Prolif. 2008 ; 41 (2). 336-347
20. Li RK, Mickle DA, Weisel RD, Rao V, Jia ZQ. Optimal time for cardiomyocyte transplantation to maximize myocardial function after left ventricular injury. Ann Thorac Surg. 2001 ; 72 (6). 1957-1963
21. Xing YL, Shen LH, Li HW, et al. Optimal time for human umbilical cord blood cell transplantation in rats with myocardial infarction. Chin Med J (Engl). 2009 ; 122 (23). 2833-2839
22. Ma J, Ge J, Zhang S, et al. Time course of myocardial stromal cell-derived factor 1 expression and beneficial effects of intravenously administered bone marrow stem cells in rats with experimental myocardial infarction. Basic Res Cardiol. 2005 ; 100 (3). 217-223
23. Proulx C, El-Helou V, Gosselin H, et al. Antagonism of stromal cell-derived factor-1 reduces infarct size and improves ventricular function after myocardial infarction. Pflugers Arch. 2007 ; 455 (2). 241-250
24. Tan Y, Li Y, Xiao J, et al. A novel CXCR4 antagonist derived from human SDF-1beta enhances angiogenesis in ischaemic mice. Cardiovasc Res. 2009 ; 82 (3). 513-521
25. Rehman AO, Wang CY. SDF-1alpha promotes invasion of head and neck squamous cell carcinoma by activating NF-kappa B. J Biol Chem. 2008 ; 283 (29). 19888-19894
26. Wang J, Loberg R, Taichman RS. The pivotal role of CXCL12(SDF-1)/CXCR4 axis in bone metastasis. Cancer Metastasis Rev. 2006 ; 25 (4). 573-587
27. Pirro M, Schillaci G, Romagno PF, et al. Influence of short-term rosuvastatin therapy on endothelial progenitor cells and endothelial function. J Cardiovasc Pharmacol Ther. 2009 ; 14 (1). 14-21
28. Walter DH, Rittig K, Bahlmann FH, et al. Statin therapy accelerates reendothelialization: a novel effect involving mobilization and incorporation of bone marrow-derived endothelial progenitor cells. Circulation. 2002 ; 105 (25). 3017-3024
29. Landmesser U, Engberding N, Bahlmann FH, et al. Statin-induced improvement of endothelial progenitor cell mobilization, myocardial neovascularization, left ventricular function, and survival after experimental myocardial infarction requires endothelial nitric oxide synthase. Circulation. 2004 ; 110 (14). 1933-1939
30. Spadaccio C, Pollari F, Casacalenda A, et al. Atorvastatin increases the number of endothelial progenitor cells after cardiac surgery: a randomized control study. J Cardiovasc Pharmacol. 2010 ; 55 (1). 30-38
31. Suzuki G, Iyer V, Cimato T, Canty JM. Pravastatin improves function in hibernating myocardium by mobilizing CD133 + and cKit+ bone marrow progenitor cells and promoting myocytes to reenter the growth phase of the cardiac cell cycle. Circ Res. 2009 ; 104 (2). 255-264
32. Spyridopoulos I, Haendeler J, Urbich C, et al. Statins enhance migratory capacity by upregulation of the telomere repeat-binding factor TRF2 in endothelial progenitor cells. Circulation. 2004 ; 110 (19). 3136-3142
33. Yang YJ, Qian HY, Huang J, et al. Atorvastatin treatment improves survival and effects of implanted mesenchymal stem cells in post-infarct swine hearts. Eur Heart J. 2008 ; 29 (12). 1578-1590
34. Yang YJ, Qian HY, Huang J, et al. Combined therapy with simvastatin and bone marrow-derived mesenchymal stem cells increases benefits in infarcted swine hearts. Arterioscler Thromb Vasc Biol. 2009 ; 29 (12). 2076-2082